About BDR Lifesciences Private Limited
Data last updated:
BDR Lifesciences Private Limited is a private limited company based in Vadodara, Gujarat, India, a subsidiary of Bdr Pharmaceuticals International Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 September 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1993PTC020258. Its GSTIN is 24AABCM3101A1ZJ (Gujarat).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.29 Cr. It was formerly known as Mj Chempharm Private Limited and Macrolide Antibiotics Limited. It is led by directors including Ketan Suresh Shah and Trushit Pramodray Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vadodara, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹176.87 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹4.04 Cr (net margin 2.3%) and EBITDA of ₹12.03 Cr (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 5% over five years.
The company has about 263 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: BDR Pharmaceuticals Internationals. As per MCA filings, the company has satisfied charges of ₹8.65 Cr on record. Court records list 14 cases involving the company, including 4 filed by the company and 10 filed against it. The company has 5 deals on record (5 secondary share transfers); the latest was in December 2022. Its 9 peer companies in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Naxpar Pharma Private Limited with revenue of ₹183.89 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2024, listing 2,549 overdue payments to 130 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bdrpharma.com.
Company details
Name history
BDR Lifesciences has undergone 5 name changes throughout its history. The current legal name is Bdr Lifesciences Private Limited.
| Company Name | Status |
|---|---|
| BDR Lifesciences Private Limited | Current |
| Mj Chempharm Private Limited | Previous |
| Macrolide Antibiotics Limited | Previous |
| Macrolide Antibiotics Private Limited | Previous |
| Macrolide Anitibiotics Limited | Previous |
| Macrolide Anitibiotics Private Limited | Previous |
CIN history
BDR Lifesciences has one previous CIN (Corporate Identification Number): U24230GJ1993PLC020258. The current CIN is U24230GJ1993PTC020258, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ1993PTC020258 | Current |
| U24230GJ1993PLC020258 | Previous |
Contact details
BDR Lifesciences Private Limited's registered office is in Vadodara, Gujarat. Its website is bdrpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressR S No 578 579/A Village Luna Ecp Road, Taluka – Padra, Vadodara, Gujarat, India – 391440
- IndustryPharma, Drug Formulation & Development
To see the full contact details of BDR Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
BDR Lifesciences operates one associated brand: BDR Pharmaceuticals Internationals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs and finished products are developed and manufactured. | bdrpharma.com |
Business activity
The main business activity of BDR Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of BDR Lifesciences Private Limited, buy the company report.
Financials of BDR Lifesciences Private Limited
FY 2025 filings availableBDR Lifesciences Private Limited reported revenue of ₹176.87 Cr (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.03 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of BDR Lifesciences Private Limited, buy the company report.
Board of directors of BDR Lifesciences Private Limited
BDR Lifesciences has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ketan Suresh Shah | Director | 05 Jul 2010 | 16 Years 4 Months | Current |
| Trushit Pramodray Mehta | Director | 01 Nov 2012 | 14 Years 0 Months | Current |
| Sanjay Amritlal Solanki Also directs: Nimbasia Stabilizers LLP, Peekay Synthetics Private Limited, Sunshine Organics Pvt Ltd and 1 more | Director | 12 Dec 2009 | 16 Years 10 Months | Current |
| Dheer Dharmesh Shah | Director | 30 May 2018 | 8 Years 5 Months | Current |
| Tejash Vijay Shah Also directs: Majorelle LLP, BDR Pharmaceuticals International Private Limited, Magnum Chemi-Gran Private Limited and 1 more | Director | 19 Apr 2021 | 5 Years 6 Months | Current |
| Raheel Dharmesh Shah Also directs: Sunshine Organics Pvt Ltd, Virdev Intermediates Private Limited, BDR Pharmaceuticals International Private Limited and 3 more | Director | 29 Jul 2011 | 15 Years 3 Months | Current |
Peer comparison
BDR Lifesciences Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Naxpar Pharma Private Limited | ₹183.89 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Infutec Healthcare Limited | ₹183.11 Cr (FY 2021) | -22.0% | Mumbai, Maharashtra, India | |||
| Sakar Healthcare Limited | ₹178.9 Cr (FY 2025) | 14.0% | Changodar, Gujarat, India | |||
| Stanford Laboratories Private Ltd | ₹178.12 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Mahima Lifesciences Private Limited | ₹177.98 Cr (FY 2025) | -18.0% | Delhi, India | |||
| BDR Lifesciences Private Limitedthis company | ₹176.87 Cr (FY 2025) | ₹4.04 Cr | 2.3% | -5.0% | 263 | Vadodara, Gujarat, India |
| Bakson Drugs and Pharmaceuticals Private Limited | ₹172.81 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Shree Krishnakeshav Laboratories Limited | ₹170.52 Cr (FY 2025) | 13.0% | Ahmedabad, Gujarat, India | |||
| Natural Capsules Limited | ₹169.91 Cr (FY 2025) | 8.0% | Bengaluru, Karnataka, India | |||
| Stericon Pharma Private Limited | ₹169.15 Cr (FY 2025) | 21.0% | Bangalore, Karnataka, India |
To see the full peer comparison of BDR Lifesciences Private Limited, buy the company report.
Auditor
BDR Lifesciences Private Limited is audited by R. C. Thakkar & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. C. Thakkar & Associates | FY 2023 | 118729W |
Shareholding
The shareholding of BDR Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of BDR Lifesciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Mar 1999 | 90102665 | Idbi Bank Ltd. | ₹8.65 Cr | Satisfied |
To see the full charge records of BDR Lifesciences Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
BDR Lifesciences Private Limited has 5 deals on record (5 secondary share transfers); the latest was in December 2022.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Secondary share transfer | Undisclosed | Buyer: BDR Pharmaceuticals International Private Limited Seller: 2 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: BDR Pharmaceuticals International Private Limited Seller: an individual |
| Jul 2010 | Secondary share transfer | Undisclosed | Buyer: BDR Pharmaceuticals International Private Limited , an individual Seller: M J International, Fine Fragrances Private Limited , Amol J Shah HUF, an individual |
| Feb 2007 | Secondary share transfer | Undisclosed | Buyer: Sanjay A Solanki HUF & Renu Solanki, 3 individuals Seller: M J Holdings and Leasing Ltd |
| Dec 2006 | Secondary share transfer | Undisclosed | Buyer: Sanjay A Solanki HUF & Renu Solanki, 3 individuals Seller: Fine Fragrances Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
BDR Lifesciences Private Limited has 14 court cases on record: 4 filed by BDR Lifesciences, 10 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 8 | 0 |
| District courts | 5 | 2 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Criminal complaint | Filed by the company against Wellcure Pharma India Pvt Ltd and 2 others | Disposed |
| District court, Vadodara, Gujarat | Commercial matter | Filed against the company by an individual | Disposed |
| High Court of Delhi | Court case (FAO(OS)) | Filed by the company against Bristol-Myers Squibb Company & Anr | Disposed |
| Bombay High Court | Court case (APP) | Filed against the company by Bayer Corporation and Another | Disposed |
| Bombay High Court | Court case (CHS) | Filed against the company by Bayer Corporation and Anr | Disposed |
To see the full case history of BDR Lifesciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
BDR Lifesciences Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 2,549 overdue payments to 130 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 130)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of BDR Lifesciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
BDR Lifesciences Private Limited has a workforce of 263 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
GST
BDR Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCM3101A1ZJ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of BDR Lifesciences Private Limited, buy the company report.
Recent activity
BDR Lifesciences Private Limited has 14 board changes on record since 2000: 10 appointments and 4 cessations. The latest: Chandrashekhar Jagdishchandra Lohani ceased to be Director on 10 Feb 2023.
7 earlier events are in the company report.
News
Frequently asked questions
BDR Lifesciences is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 September 1993 (33+ years old) and is registered under CIN U24230GJ1993PTC020258.
BDR Lifesciences has 6 current directors:
- Ketan Suresh Shah - Director
- Trushit Pramodray Mehta - Director
- Sanjay Amritlal Solanki - Director
- Dheer Dharmesh Shah - Director
- Tejash Vijay Shah - Director
- Raheel Dharmesh Shah - Director
The latest financial statements of BDR Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of BDR Lifesciences is 24AABCM3101A1ZJ, registered in Gujarat.
The CIN (Corporate Identification Number) of BDR Lifesciences is U24230GJ1993PTC020258. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
BDR Lifesciences has 14 court cases on record: 4 filed by the company and 10 filed against it. Most are in the high courts.
BDR Lifesciences was incorporated on 24 September 1993, making it 33+ years old. It is registered with the Registrar of Companies, Ahmedabad.
BDR Lifesciences has 5 deals on record (5 secondary share transfers); the latest was in December 2022.
The peers of BDR Lifesciences by revenue are Naxpar Pharma Private Limited, Infutec Healthcare Limited, Sakar Healthcare Limited, Stanford Laboratories Private Ltd, Mahima Lifesciences Private Limited and 4 more, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandrashekhar Jagdishchandra Lohani ceased to be Director on 10 Feb 2023. Chandrashekhar Jagdishchandra Lohani was appointed as Director on 19 Apr 2021. Tejash Vijay Shah was appointed as Director on 19 Apr 2021. BDR Lifesciences has 14 board changes on record in total.
BDR Lifesciences has 13 MSME Form 1 returns on record between 2019 and 2024, listing 2,549 overdue payments to 130 micro and small suppliers. The latest return was filed on 20 Apr 2024.
BDR Lifesciences can be reached through the website bdrpharma.com. Its registered office is in Vadodara, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
